Stockscreener 앱 받기
1.545
3.00%
0.045
Marinus Pharmaceuticals Inc 주식(MRNS)의 최신 뉴스
Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024 - BioSpace
Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024 - StockTitan
Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference - StockTitan
Marinus Pharmaceuticals (NASDAQ:MRNS) Earns "Overweight" Rating from Cantor Fitzgerald - MarketBeat
Marinus Pharmaceuticals (NASDAQ:MRNS) Stock Rating Upgraded by StockNews.com - MarketBeat
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $12.75 Average PT from Analysts - MarketBeat
Marinus Pharmaceuticals Inc (MRNS) may enjoy gains as insiders got busy in the recent days - Knox Daily
Marinus Pharmaceuticals Hosts Investor and Analyst Day - MyChesCo
Marinus Pharmaceuticals (NASDAQ:MRNS) Downgraded by StockNews.com to "Sell" - MarketBeat
Marinus Pharmaceuticals Reports Robust Q2 2024 Financial Results and Business Progress - MyChesCo
Cantor Fitzgerald Weighs in on Marinus Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:MRNS) - MarketBeat
Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024 - StockTitan
Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024 - Business Wire
LADENBURG THALM/SH SH Lowers Marinus Pharmaceuticals (NASDAQ:MRNS) to Neutral - Defense World
Marinus Pharmaceuticals (LTS:0JYL) Asset Turnover : 0.07 (As of Jun. 2024) - GuruFocus.com
Q3 2024 EPS Estimates for Marinus Pharmaceuticals, Inc. Reduced by HC Wainwright (NASDAQ:MRNS) - MarketBeat
Leerink Partnrs Brokers Cut Earnings Estimates for Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Stock Rating Reaffirmed by HC Wainwright - Defense World
Marinus Pharmaceuticals, Inc. Expected to Post Q3 2024 Earnings of ($0.47) Per Share (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Simply Wall St
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Thinking about buying stock in Archer Aviation, Marinus Pharmace - GuruFocus.com
Marinus Pharmaceuticals, Inc. Forecasted to Earn FY2028 Earnings of $2.72 Per Share (NASDAQ:MRNS) - MarketBeat
Marinus Pharmaceuticals, Inc. Forecasted to Earn FY2028 Earnings of $2.72 Per Share (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Upgraded by StockNews.com to Hold - Defense World
Marinus Pharmaceuticals (NASDAQ:MRNS) Given "Buy" Rating at HC Wainwright - MarketBeat
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com
Global Maternal Mental Health Market to Exhibit Growth at Tremendous CAGR of ~15% by 2030 | DelveInsight - GlobeNewswire Inc.
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com Australia
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com Canada
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com India
Marinus Pharmaceuticals Inc (MRNS) Q2 2024 Earnings Call Transcr - GuruFocus.com
Company News for Aug 14, 2024 - MSN
Marinus Pharma stock hits 52-week low at $1.09 amid downturn - Investing.com UK
Company News for Aug 14, 2024 - Yahoo Finance
Marinus Pharmaceuticals (NASDAQ:MRNS) Cut to Neutral at LADENBURG THALM/SH SH - MarketBeat
Marinus Pharmaceuticals: Q2 Earnings Snapshot - Darien Times
MRNS Investors Have Opportunity to Lead Marinus Pharmaceuticals, Inc. Securities Fraud Lawsuit - Longview News-Journal
Marinus Pharmaceuticals maintains Buy rating with $10 target By Investing.com - Investing.com Canada
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth By Investing.com - Investing.com Australia
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth By Investing.com - Investing.com Canada
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth - Investing.com India
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth - Investing.com
Earnings call: Marinus Pharmaceuticals reports steady ZTALMY growth By Investing.com - Investing.com UK
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - citybiz
Marinus Pharmaceuticals: Q2 Earnings Snapshot - San Francisco Chronicle
Marinus Pharmaceuticals: Q2 Earnings Snapshot - The Washington Post
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - Lelezard
Marinus Pharmaceuticals (MRNS) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Canada Finance
Marinus Pharma falls after missing Q2 revenue estimates - XM
Marinus Pharmaceuticals: Q2 Earnings Snapshot - CTPost
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - Winchester Herald Chronicle
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results - Business Wire
Even after rising 11% this past week, Marinus Pharmaceuticals (NASDAQ:MRNS) shareholders are still down 90% over the past three years - Simply Wall St
Vanguard Group Inc. Purchases 132,689 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) - Defense World
Marinus Pharmaceuticals (MRNS) to Release Quarterly Earnings on Tuesday - Defense World
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Receives $12.75 Consensus Target Price from Analysts - MarketBeat
Scott Braunstein Sells 12,145 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Stock - Defense World
Scott Braunstein Sells 12,145 Shares of Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) Stock - MarketBeat
A company insider recently sold 2,153 shares of Marinus Pharmaceuticals Inc [MRNS]. Should You also Consider to Sale? – Knox Daily - Knox Daily
There is no way Marinus Pharmaceuticals Inc (MRNS) can keep these numbers up - SETE News
Marinus Pharmaceuticals (MRNS) to Release Earnings on Tuesday - MarketBeat
Marinus Pharmaceuticals Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Closing Bell Recap: Marinus Pharmaceuticals Inc (MRNS) Ends at 1.10, Reflecting a -15.38 Downturn - The Dwinnex
Technical analysis of Marinus Pharmaceuticals Inc (MRNS) stock chart patterns - US Post News
3 Biotech Stocks to Sell in August Before They Crash & Burn - InvestorPlace
1.26%
1.71%
자본화:
|
볼륨(24시간):